Ha, Tuanzhu, Hua, Fang, Liu, Xiang, Ma, Jing, McMullen, Julie R., Shioi, Tetsuo, ...
Aims The ability of lipopolysaccharide (LPS) pre-treatment to induce cardioprotection following ischaemia/reperfusion (I/R) has been well documented; however, the mechanisms have not been fully...
David L. Williams, John Kalbfleisch, I. William Browder, Race L. Kao, Chuanfu Li, First Published Jun, ...
doi:10.1152/ajpheart.01264.2005 You might find this additional information useful... This article cites 51 articles, 19 of which you can access free at:
Ha, Tuanzhu, Li, Yuehua, Hua, Fang, Ma, Jinag, Gao, Xiang, Kelley, Jim, ...
Objective: We have previously demonstrated that nuclear factor kappa B (NFB) activation is needed for the development of cardiac hypertrophy in vivo. NFB is a downstream transcription factor in the...
Li, Chuanfu, Ha, Tuanzhu, Kelley, Jim, Gao, Xiang, Qiu, Yufeng, Kao, Race L, ...
Objective: Immune and inflammatory signaling pathways, initiated by the innate response, are involved in myocardial ischemia/reperfusion (I/R) injury. Toll-like receptor (TLR) mediated...
Mechanical Circulatory Assist Devices
Magovern, George J., Park, Sang B., Magovern, George J., Christlieb, Ignacio Y., Kao, Race L.
Cardiogenic shock occurs in about 10% of the 1.5 million patients who suffer myocardial infarction and in approximately 1% of the 200,000 patients who undergo open-heart surgery each year. The...
Mechanical Circulatory Assist Devices
Magovern, George J., Park, Sang B., Magovern, George J., Christlieb, Ignacio Y., Kao, Race L.
Cardiogenic shock occurs in about 10% of the 1.5 million patients who suffer myocardial infarction and in approximately 1% of the 200,000 patients who undergo open-heart surgery each year. The...